药理学
对接(动物)
山奈酚
医学
化学
生物化学
类黄酮
抗氧化剂
护理部
作者
Shuxin FU,Fangping DENG,Dandan LI,Shuo QI,Xiaoyi Zhang,Hong Zou,Qun Li
出处
期刊:
[Elsevier BV]
日期:2025-09-03
卷期号:54 (1): 100618-100618
被引量:1
标识
DOI:10.1016/j.cjac.2025.100618
摘要
Through integrated network pharmacology and molecular docking techniques, this investigation elucidated the potential mechanisms of kaempferol in treating oral submucosal fibrosis. Related genes were screened in the appropriate databases, and there were 94 cross-gene overlaps between 518 target proteins of kaempferol and 969 potential targets of oral submucous fibrosis. 10 core targets were pinpointed by analyzing the PPI network topology of 94 targets, including MMP9, IL6, TNF, ALB, and so on. GO and KEGG enrichment analysis demonstrated that kaempferol affects oral submucosal fibrosis mainly by mediating TNF, IL-17, TLR, PI3K-AKT, and other pathways. Molecular docking utilizing AutoDock Vina 4.2 software indicated that kaempferol had strong binding energy to all core targets. Kaempferol treats oral submucosal fibrosis by targeting multiple key target genes and regulating TNF, IL-17, and other signaling pathways, reflecting the multi-target, multi-pathway nature of kaempferol's antifibrotic effects.
科研通智能强力驱动
Strongly Powered by AbleSci AI